Protein disulfide bonds are the links between the sulfur atoms of two cysteine amino acids. All the known life forms appear to make this bond. Most disulfide bonds perform a structural role by stabilizing the tertiary and quaternary structures. Some perform a functional role and can be characterized as either catalytic or allosteric disulfides. Catalytic disulfides/dithiols transfer electrons between proteins, whereas the allosteric bonds control the function of the protein in which they reside when they undergo redox change. There are currently five clear examples of allosteric disulfide bonds and a number of potential allosteric disulfides at various stages of characterization. The features of these bonds and how they control the activity of the respective proteins are discussed. A common aspect of the allosteric disulfides identified to date is that they all link β-strands or β-loops. Antioxid. Redox Signal. 14, 113–126.
Get full access to this article
View all access options for this article.
References
1.
AhamedJ, VersteegHH, KerverM, ChenVM, MuellerBM, HoggPJ, RufW. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A, 103:13932–13937. 2006.
2.
AuwerxJ, IsacssonO, SoderlundJ, BalzariniJ, JohanssonM, LundbergM. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication. Int J Biochem Cell Biol, 41:1269–1275. 2009.
3.
AzimiI, MatthiasLJ, CenterRJ, WongJWH, HoggPJ. The disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin. J Biol Chem(In press).
BarboucheR, MiquelisR, JonesIM, FenouilletE. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem, 278:3131–3136. 2003.
6.
BeggGE, CarringtonL, StokesPH, MatthewsJM, WoutersMA, HusainA, LorandL, IismaaSE, GrahamRM. Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci U S A, 103:19683–19688. 2006.
7.
BerndtC, LilligCH, HolmgrenA. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta, 1783:641–650. 2008.
8.
BoumaB, de GrootPG, van den ElsenJM, RavelliRB, SchoutenA, SimmelinkMJ, DerksenRH, KroonJ, GrosP. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J, 18:5166–5174. 1999.
9.
BourgeoisR, MercierJ, Paquette-BrooksI, CohenEA. Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry. Retrovirology, 3:31. 2006.
10.
BrooksDJ, FrescoJR, LeskAM, SinghM. Evolution of amino acid frequencies in proteins over deep time: inferred order of introduction of amino acids into the genetic code. Mol Biol Evol, 19:1645–1655. 2002.
11.
ChenVM, AhamedJ, VersteegHH, BerndtMC, RufW, HoggPJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry, 45:12020–12028. 2006.
12.
ChenVM, HoggPJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost, 4:2533–2541. 2006.
13.
ChoJ, FurieBC, CoughlinSR, FurieB. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest, 118:1123–1131. 2008.
14.
ChoiH, AboulfatovaK, PownallHJ, CookR, DongJF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem, 282:35604–35611. 2007.
15.
ChungSI, FolkJE. Mechanism of the inactivation of guinea pig liver transglutaminase by tetrathionate. J Biol Chem, 245:681–689. 1970.
16.
ColletJF, RiemerJ, BaderMW, BardwellJC. Reconstitution of a disulfide isomerization system. J Biol Chem, 277:26886–26892. 2002.
17.
ConnellanJM, FolkJE. Mechanism of the inactivation of guinea pig liver transglutaminase by 5,5′-dithiobis-(2-nitrobenzoic acid)J Biol Chem, 244:3173–3181. 1969.
18.
CountsRB, PaskellSL, ElgeeSK. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor. J Clin Invest, 62:702–709. 1978.
19.
DongJF. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost, 3:1710–1716. 2005.
20.
EinfeldD. Maturation and assembly of retroviral glycoproteins. Curr Top Microbiol Immunol, 214:133–176. 1996.
21.
EssexDW. Redox control of platelet function. Antioxid Redox Signal, 11:1191–1225. 2009.
22.
EssexDW, ChenK, SwiatkowskaM. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood, 86:2168–2173. 1995.
23.
EssexDW, LiM. Redox control of platelet aggregation. Biochemistry, 42:129–136. 2003.
24.
FernandesPA, RamosMJ. Theoretical insights into the mechanism for thiol/disulfide exchange. Chemistry, 10:257–266. 2004.
25.
FischerA, MontalM. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem, 282:29604–29611. 2007.
26.
FurieB, FurieBC. Mechanisms of thrombus formation. N Engl J Med, 359:938–949. 2008.
27.
FurlanM. Von Willebrand factor: molecular size and functional activity. Ann Hematol, 72:341–348. 1996.
28.
GallinaA, HanleyTM, MandelR, TraheyM, BroderCC, VigliantiGA, RyserHJ. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem, 277:50579–50588. 2002.
29.
GalloSA, FinneganCM, ViardM, RavivY, DimitrovA, RawatSS, PuriA, DurellS, BlumenthalR. The HIV Env-mediated fusion reaction. Biochim Biophys Acta, 1614:36–50. 2003.
30.
GandertonT, BerndtMC, ChestermanCN, HoggPJ. Hypothesis for control of von Willebrand factor multimer size by intra-molecular thiol-disulphide exchange. J Thromb Haemost, 5:204–206. 2007.
31.
Garcia AbreuJ, CoffinierC, LarrainJ, OelgeschlagerM, De RobertisEM. Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene, 287:39–47. 2002.
32.
GarrettTP, WangJ, YanY, LiuJ, HarrisonSC. Refinement and analysis of the structure of the first two domains of human CD4. J Mol Biol, 234:763–778. 1993.
33.
GiannakopoulosB, PassamF, IoannouY, KrilisSA. How we diagnose the antiphospholipid syndrome. Blood, 113:985–994. 2009.
34.
GonzalezS, GrohV, SpiesT. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol, 298:121–138. 2006.
35.
GopalanG, HeZ, BalmerY, RomanoP, GuptaR, HerouxA, BuchananBB, SwaminathanK, LuanS. Structural analysis uncovers a role for redox in regulating FKBP13, an immunophilin of the chloroplast thylakoid lumen. Proc Natl Acad Sci U S A, 101:13945–13950. 2004.
GrimshawJP, StirnimannCU, BrozzoMS, MalojcicG, GrutterMG, CapitaniG, GlockshuberR. DsbL and DsbI form a specific dithiol oxidase system for periplasmic arylsulfate sulfotransferase in uropathogenic Escherichia coli. J Mol Biol, 380:667–680. 2008.
38.
GrohV, BahramS, BauerS, HermanA, BeauchampM, SpiesT. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A, 93:12445–12450. 1996.
39.
GrohV, RhinehartR, SecristH, BauerS, GrabsteinKH, SpiesT. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A, 96:6879–6884. 1999.
40.
HoggPJ. Disulfide bonds as switches for protein function. Trends Biochem Sci, 28:210–214. 2003.
41.
HuangCC, StricherF, MartinL, DeckerJM, MajeedS, BartheP, HendricksonWA, RobinsonJ, RoumestandC, SodroskiJ, WyattR, ShawGM, VitaC, KwongPD. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure, 13:755–768. 2005.
IoannouY, ZhangJ-Y, PassamFH, RahgozarS, QiJC, GiannakopoulosB, YuMQP, YuDM, HoggPJ, KrilisSA. Naturally occurring free thiols within ß2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells and regulation of oxidative stress induced cell injury. Blood, 116:1995–1997. 2010.
44.
Jacob-DubuissonF, PinknerJ, XuZ, StrikerR, PadmanhabanA, HultgrenSJ. PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA. Proc Natl Acad Sci U S A, 91:11552–11556. 1994.
45.
JiangXM, FitzgeraldM, GrantCM, HoggPJ. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem, 274:2416–2423. 1999.
46.
JonesDT, TaylorWR, ThorntonJM. The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci, 8:275–282. 1992.
47.
JordanIK, KondrashovFA, AdzhubeiIA, WolfYI, KooninEV, KondrashovAS, SunyaevS. A universal trend of amino acid gain and loss in protein evolution. Nature, 433:633–638. 2005.
KrauseG, LundstromJ, BareaJL, Pueyo de la CuestaC, HolmgrenA. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J Biol Chem, 266:9494–9500. 1991.
50.
LaiTS, LiuY, TuckerT, DanielKR, SaneDC, TooneE, BurkeJR, StrittmatterWJ, GreenbergCS. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol, 15:969–978. 2008.
51.
LeDT, RapaportSI, RaoLV. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem, 267:15447–15454. 1992.
52.
LiP, MorrisDL, WillcoxBE, SteinleA, SpiesT, StrongRK. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol, 2:443–451. 2001.
53.
LiP, WillieST, BauerS, MorrisDL, SpiesT, StrongRK. Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity, 10:577–584. 1999.
54.
LiY, ChoiH, ZhouZ, NolascoL, PownallHJ, VoorbergJ, MoakeJL, DongJF. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost, 6:1135–1143. 2008.
55.
LiangHP, HoggPJ. Critical importance of the cell system when studying tissue factor de-encryption. Blood, 112:912–913; author reply 9132008.
LukenBM, WinnLY, EmsleyJ, LaneDA, CrawleyJT. The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function. Blood, 115:4910–4913. 2010.
58.
LundstromJ, HolmgrenA. Determination of the reduction-oxidation potential of the thioredoxin-like domains of protein disulfide-isomerase from the equilibrium with glutathione and thioredoxin. Biochemistry, 32:6649–6655. 1993.
59.
MaekawaA, SchmidtB, Fazekas de St GrothB, SanejouandYH, HoggPJ. Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J Immunol, 176:6873–6878. 2006.
60.
MalojcicG, OwenRL, GrimshawJP, BrozzoMS, Dreher-TeoH, GlockshuberR. A structural and biochemical basis for PAPS-independent sulfuryl transfer by aryl sulfotransferase from uropathogenic Escherichia coli. Proc Natl Acad Sci U S A, 105:19217–19222. 2008.
61.
MarkovicI, StantchevTS, FieldsKH, TiffanyLJ, TomicM, WeissCD, BroderCC, StrebelK, ClouseKA. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood, 103:1586–1594. 2004.
62.
MatthiasLJ, AzimiI, TabrettCA, HoggPJ. Reduced monomeric CD4 is the preferred receptor for HIV. J Biol Chem, 2010Oct25[Epub ahead of print].
63.
MatthiasLJ, YamPT, JiangXM, VandegraaffN, LiP, PoumbouriosP, DonoghueN, HoggPJ. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol, 3:727–732. 2002.
64.
MichauxG, AbbittKB, CollinsonLM, HaberichterSL, NormanKE, CutlerDF. The physiological function of von Willebrand's factor depends on its tubular storage in endothelial Weibel-Palade bodies. Dev Cell, 10:223–232. 2006.
65.
MillsJE, WhitfordPC, ShafferJ, OnuchicJN, AdamsJA, JenningsPA. A novel disulfide bond in the SH2 domain of the C-terminal Src kinase controls catalytic activity. J Mol Biol, 365:1460–1468. 2007.
66.
MiyakisS, GiannakopoulosB, KrilisSA. Beta 2 glycoprotein I—function in health and disease. Thromb Res, 114:335–346. 2004.
67.
MoldovanMC, YachouA, LevesqueK, WuH, HendricksonWA, CohenEA, SekalyRP. CD4 dimers constitute the functional component required for T cell activation. J Immunol, 169:6261–6268. 2002.
68.
MontalM. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem, 79:591–617. 2010.
69.
Mor-CohenR, RosenbergN, LandauM, LahavJ, SeligsohnU. Specific cysteines in beta3 are involved in disulfide bond exchange-dependent and -independent activation of alphaIIbbeta3. J Biol Chem, 283:19235–19244. 2008.
O'LearyJM, HamiltonJM, DeaneCM, ValeyevNV, SandellLJ, DowningAK. Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand Factor type C module) from collagen IIA. J Biol Chem, 279:53857–53866. 2004.
72.
OstergaardH, HenriksenA, HansenFG, WintherJR. Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein. EMBO J, 20:5853–5862. 2001.
73.
OuW, SilverJ. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. Virology, 350:406–417. 2006.
74.
PassamFH, RahgozarS, QiM, RafteryMJ, WongJWH, TanakaK, IoannouY, ZhangJY, GemmellR, QiJC, GiannakopoulosB, HughesWE, HoggPJ, KrilisSA. Redox control of β2-glycoprotein I–von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost, 8:1754–1762. 2010.
75.
PassamFH, RahgozarS, QiM, RafteryMJ, WongJWH, TanakaK, IoannouY, ZhangJY, GemmellR, QiJC, HughesWE, HoggPJ, KrilisSA. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood, 116:1995–1997. 2010.
76.
PendurthiUR, GhoshS, MandalSK, RaoLV. Tissue factor activation: is disulfide bond switching a regulatory mechanism?Blood, 110:3900–3908. 2007.
77.
PerssonE. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor. Thromb Res, 123:171–176. 2008.
78.
PiatekR, ZalewskaB, KolajO, FerensM, NowickiB, KurJ. Molecular aspects of biogenesis of Escherichia coli Dr Fimbriae: characterization of DraB-DraE complexes. Infect Immun, 73:135–145. 2005.
79.
PinkasDM, StropP, BrungerAT, KhoslaC. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol, 5:e327. 2007.
80.
PloplisVA, EdgingtonTS, FairDS. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem, 262:9503–9508. 1987.
81.
RaturiA, MierschS, HudsonJW, MutusB. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochim Biophys Acta, 1778:2790–2796. 2008.
82.
ReinhardtC, von BruhlML, ManukyanD, GrahlL, LorenzM, AltmannB, DlugaiS, HessS, KonradI, OrschiedtL, MackmanN, RuddockL, MassbergS, EngelmannB. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest, 118:1110–1122. 2008.
83.
RichardsonJ, RichardsonD. Prediction of Protein Structure and the Principles of Protein Conformation. New York: Plenum Press, 1989; 1–99.
84.
RozhkovaA, GlockshuberR. Thermodynamic aspects of DsbD-mediated electron transport. J Mol Biol, 380:783–788. 2008.
85.
RyserHJ, LevyEM, MandelR, DiSciulloGJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci U S A, 91:4559–4563. 1994.
86.
SakaiT, Lund-HansenT, PaborskyL, PedersenAH, KisielW. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem, 264:9980–9988. 1989.
87.
SanejouandYH. Domain swapping of CD4 upon dimerization. Proteins, 57:205–212. 2004.
88.
SauerFG, PinknerJS, WaksmanG, HultgrenSJ. Chaperone priming of pilus subunits facilitates a topological transition that drives fiber formation. Cell, 111:543–551. 2002.
SchmidtB, HoggPJ. Search for allosteric disulfide bonds in NMR structures. BMC Struct Biol, 7:49. 2007.
91.
SchwarzenbacherR, ZethK, DiederichsK, GriesA, KostnerGM, LaggnerP, PrasslR. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J, 18:6228–6239. 1999.
SiegelM, KhoslaC. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther, 115:232–245. 2007.
94.
SwaminathanS, EswaramoorthyS. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol, 7:693–699. 2000.
95.
SwiatkowskaM, SzymanskiJ, PadulaG, CierniewskiCS. Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J, 275:1813–1823. 2008.
96.
TsaiHM. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost, 29:479–488. 2003.
97.
VersteegHH, RufW. Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. J Biol Chem, 282:25416–25424. 2007.
98.
WiitaAP, Perez-JimenezR, WaltherKA, GraterF, BerneBJ, HolmgrenA, Sanchez-RuizJM, FernandezJM. Probing the chemistry of thioredoxin catalysis with force. Nature, 450:124–127. 2007.
99.
WongJWH, HoSYW, HoggPJ. Disulfide bond acquisition through eukaryotic protein evolution. Mol Biol Evol, 2010Jul 30 [Epub ahead of print].
100.
WoutersMA, LauKK, HoggPJ. Cross-strand disulphides in cell entry proteins: poised to act. Bioessays, 26:73–79. 2004.
101.
XieL, ChestermanCN, HoggPJ. Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med, 193:1341–1349. 2001.
102.
XiongJP, MahalinghamB, AlonsoJL, BorrelliLA, RuiX, AnandS, HymanBT, RysiokT, Muller-PompallaD, GoodmanSL, ArnaoutMA. Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J Cell Biol, 186:589–600. 2009.
103.
Zav'yalovVP, ChernovskayaTV, ChapmanDA, KarlyshevAV, MacIntyreS, ZavialovAV, VasilievAM, DenesyukAI, Zav'yalovaGA, DudichIV, KorpelaT, AbramovVM. Influence of the conserved disulphide bond, exposed to the putative binding pocket, on the structure and function of the immunoglobulin-like molecular chaperone Caf1M of Yersinia pestis. Biochem J 324 (Pt, 2):571–578. 1997.
104.
ZhangJL, HuangY, QiuLY, NickelJ, SebaldW. von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms. J Biol Chem, 282:20002–20014. 2007.
105.
ZhangJL, QiuLY, KotzschA, WeidauerS, PattersonL, HammerschmidtM, SebaldW, MuellerTD. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell, 14:739–750. 2008.
106.
ZhangQ, ZhouYF, ZhangCZ, ZhangX, LuC, SpringerTA. Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A, 106:9226–9231. 2009.
107.
ZhangX, HalvorsenK, ZhangCZ, WongWP, SpringerTA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science, 324:1330–1334. 2009.
108.
ZhuJ, LuoBH, XiaoT, ZhangC, NishidaN, SpringerTA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell, 32:849–861. 2008.
